Risk factors for parenteral nutrition-associated liver disease following surgical therapy for necrotizing enterocolitis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 52, Issue 5, 2011, Pages 595-600

  Duro, Debora ^a,h   Mitchell, Paul D ^a   Kalish, Leslie A ^a   Martin, Cami ^b   McCarthy, Maggie ^a   Jaksic, Tom ^a   Dunn, James ^c   Brandt, Mary L ^d   Nobuhara, Kerilyn K ^e   Sylvester, Karl G ^f   Moss, R Lawrence ^g   Duggan, Christopher ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF MIAMI   (United States)

Author keywords

Intestinal failure; jejunostomy; necrotizing enterocolitis; parenteral nutrition associated liver disease; short bowel syndrome

Indexed keywords

BILIRUBIN;

ARTICLE; BILIRUBIN BLOOD LEVEL; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; INTESTINE SURGERY; JEJUNOSTOMY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NECROTIZING ENTEROCOLITIS; NEWBORN; PARENTERAL NUTRITION; PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

BILIRUBIN; ENTEROCOLITIS, NECROTIZING; FEMALE; GESTATIONAL AGE; HUMANS; INCIDENCE; INFANT; INTESTINAL DISEASES; INTESTINE, SMALL; JEJUNOSTOMY; LIVER DISEASES; LOGISTIC MODELS; MALE; ODDS RATIO; PARENTERAL NUTRITION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SEX FACTORS;

EID: 79955555959     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31820e8396     Document Type: Article

References (22)

1. Dorney SF, Ament ME, Berquist WE, et al. Improved survival in very short small bowel of infancy with use of long-term parenteral nutrition. J Pediatr 1985;107:521-5. (Pubitemid 16216718)
2. Stanko RT, Nathan G, Mendelow H, et al. Development of hepatic cholestasis and fibrosis in patients with massive loss of intestine supported by prolonged parenteral nutrition. Gastroenterology 1987; 92:197-202. (Pubitemid 17207681)
3. Buchman AL, Iyer K, Fryer J. Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation. Hepatology 2006;43:9-19. (Pubitemid 43733585)
4. Btaiche IF, Khalidi N. Parenteral nutrition-associated liver complications in children. Pharmacotherapy 2002;22:188-211. (Pubitemid 34112881)
5. Buchman A. Total parenteral nutrition-associated liver disease. JPEN J Parenter Enteral Nutr 2002;26:S43-8. (Pubitemid 34924936)
6. Quiros-Tejeira RE, Ament ME, Reyen L, et al. Long-term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: a 25-year experience. J Pediatr 2004;145: 157-63. (Pubitemid 38993385)
7. Andorsky DJ, Lund DP, Lillehei CW, et al. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr 2001;139:27-33. (Pubitemid 32613983)
8. Goulet O, Ruemmele F. Causes and management of intestinal failure in children. Gastroenterology 2006;130:S16-28. (Pubitemid 43208856)
9. Beath SV, Davies P, Papadopoulou A, et al. Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors. J Pediatr Surg 1996;31:604-6. (Pubitemid 26115658)
10. Greenberg GR, Wolman SL, Christofides ND, et al. Effect of total parenteral nutrition on gut hormone release in humans. Gastroenterology 1981;80:988-93. (Pubitemid 11113041)
11. Kaufman SS, Loseke CA, Lupo JV, et al. Influence of bacterial overgrowth and intestinal inflammation on duration of parenteral nutrition in children with short bowel syndrome. J Pediatr 1997; 131:356-61. (Pubitemid 27495193)
12. Colomb V, Jobert-Giraud A, Lacaille F, et al. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr 2000;24:345-50.
13. Christensen RD, Henry E, Wiedmeier SE, et al. Identifying patients, on the first day of life, at high-risk of developing parenteral nutritionassociated liver disease. J Perinatol 2007;27:284-90. (Pubitemid 46647905)
14. Moss RL, Kalish LA, Duggan C, et al. Clinical parameters do not adequately predict outcome in necrotizing enterocolitis: a multi-institutional study. J Perinatol 2008;28:665-74.
15. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978;187:1-7.
16. Hosmer DWJ, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons, Inc; 1989.
17. Klein JP, Moeschberger ML. Survival Analysis Techniques for Censored and Truncated Data. New York: Springer Verlag; 2003.
18. Kelly DA. Intestinal failure-associated liver disease: what do we know today? Gastroenterology 2006;130:S70-7. (Pubitemid 43208863)
19. Forchielli ML, Walker WA. Nutritional factors contributing to the development of cholestasis during total parenteral nutrition. Adv Pediatr 2003;50:245-67.
20. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008;121:e678-86.
21. Duro D, Kalish LA, Johnston P, et al. Risk factors for intestinal failure in infants with necrotizing enterocolitis: a Glaser Pediatric Research Network study. J Pediatr 2010;157:203-8.
22. Goulet O, Baglin-Gobet S, Talbotec C, et al. Outcome and longterm growth after extensive small bowel resection in the neonatal period: a survey of 87 children. Eur J Pediatr Surg 2005;15: 95-101. (Pubitemid 40834266)